Neutral
Recursion (NASDAQ: RXRX) director receives 88,424-share restricted stock grant
Recursion Pharmaceuticals (NASDAQ: RXRX) director Robert Hershberg was granted 88,424 restricted stock units (RSUs) as a routine award under the compa...